Sign in
190 A Translational Study Characterizing the T-cell Signatures of IBD Patients Responding to Vedolizumab, an [alpha]4[beta]7 Integrin Blocker
Journal article   Peer reviewed

190 A Translational Study Characterizing the T-cell Signatures of IBD Patients Responding to Vedolizumab, an [alpha]4[beta]7 Integrin Blocker

Gastroenterology (New York, N.Y. 1943), Vol.150(4), p.S50
2016-04-01

Abstract

Medical research Medicine, Experimental T cells Integrins

Metrics

6 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details